AKT1 and lung cancer: Activation of the of the ATM-AMPK-p53-p21cip pathway results in the inhibition of pro-survival growth pathways such as the Akt-mTOR-4EBP1 pathway; and it also results in inhibition of lung cancer cell proliferation and induction of cell cycle arrest [29, 30].